Business

• Small Battery, Big Power: SUNGROW Unveils SBS050 5 kWh Home Battery

  

  HEFEI,China,March 4,2025--Recently,SUNGROW unveiled its 5 kWh SBS050 home energy storage battery,a game-changing solution that redefines residential energy storage. With a compact 182 mm design,SBS05

  03-05

  Details

• HONOR Introduces the Ultra-thin HONOR Pad V9 at MWC 2025

  

  BARCELONA,Spain,March 3,2025-- HONOR today announced the HONOR ALPHA PLAN,a new corporate strategy to transform HONOR from a smartphone maker to a global leading AI device ecosystem company. Funded b

  03-05

  Details

• TCL Introduces Six New Models in the TCL 60 Series, Enhancing Connectivity and User Engagement by Diversifying Portfolio

  

  BARCELONA,Spain,March 3,2025-- TCL,a pioneer in display across feature-rich smartphones,tablets,and connected devices,today expanded its TCL 60 series with the introduction of six additional smartphon

  03-05

  Details

• ESR Unveils Upgraded Digital Presence Reflecting Its Focus on Innovation and Technology

  

  Transformation fromESR Gear to ESR Tech further advances the mission of "Tech Made Easier",enhancing everyday tech experiences with innovative solutions

  03-05

  Details

• Paeonia Industries Announces Acquisition of the Savant Group of companies

  

  MIDLAND,Mich.,March 3,2025-- Paeonia Industries,a premier global firm with deep roots in analytical equipment manufacturing for energy testing,as well as the distribution of scientific testing instrum

  03-05

  Details

• CStone Announces First Patient Dosed in Global Multicenter Phase I Clinical Trial of CS2009, a PD-1/VEGF/CTLA-4 Trispecific Antibody

  

  SUZHOU,China,March 4,2025--CStone Pharmaceuticals ("CStone",HKEX: 2616),an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies,today

  03-05

  Details

• Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®

  

  STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]

  03-05

  Details

• Digital Garden Tokyo to Feature Unprecedented Speaker Lineup and Over 80 Companies Represented by C-Suite Delegations at Japan's First Global-Scale Digital Infrastructure Summit

  

  TOKYO,March 4,2025-- With just two weeks until the highly anticipated Digital Garden Tokyo,excitement is building for Japan\'s inaugural global-scale digital infrastructure summit. Taking place on Mar

  03-05

  Details

• AIFIAN Releases Asia-Pacific Investment Report: Baijiu Emerges as a Strong Investment Asset

  

  NEW YORK,March 4,2025-- AIFIAN has released its 2024 Asia-Pacific investment report,highlighting key trends in liquor investment across the region. The findings reveal that Baijiu has emerged as the

  03-05

  Details

• Turnitin launches Turnitin Clarity, bringing transparency and integrity insights to education

  

  New offering delivers a composition workspace for students with educator-guided AI assistance,assignment-to-grading workflows and integrity insights - all in one place

  03-05

  Details